Stay updated on AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Sign up to get notified when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.
Latest updates to the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page
- Check3 days agoChange DetectedResults Submitted is now shown for the study record, replacing the previous No Results Posted. The page revision has been updated to v3.3.4 (from v3.3.3).SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded the 2026 J Hepatology publication detailing the ADP-A2AFP TCR T-cell trial and removed the 2025 online-ahead-of-print citation.SummaryDifference0.0%
- Check24 days agoChange DetectedA consolidated Locations section listing all study sites across countries was added, replacing the prior per-state location subsections.SummaryDifference1%
- Check52 days agoChange DetectedThe Publications section now notes that entries are automatically filled from PubMed and may not be about the study, and the revision tag updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check60 days agoChange DetectedThe site-wide notice about government funding lapse and operation status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check67 days agoChange DetectedNo significant changes detected between the two screenshots; the study overview, eligibility criteria, and listed locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
Stay in the know with updates to AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.